Methicillin-resistant Staphylococcus aureus active metabolites
US8633166B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Inventors
Key dates
| Filing date | Mar 16, 2010 |
| Grant date | Jan 21, 2014 |
| Priority date | — |
| Expiry date | Apr 2, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This present provides kaempferol-3-(2-E,3-Z-di-p-coumaroyl)-rhamnoside, kaempferol-3-(2-Z-3-E-di-p-coumaroyl)-rhamnoside, and kaempferol-3-(2,3-di-Z-p-coumaroyl)-rhamnoside compounds useful as a new class of anti-bacterial agents. These compounds are extracted from Platanus occidentalis. These compounds were found to exhibit anti-bacterial activity against methicillin resistant Staphylococcus aureus (MRSA).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.